Medications for Hepatitis

3 results

  • Hyperhep b (hepatitis b immune globulin (human))

    (HEPATITIS B IMMUNE GLOBULIN (HUMAN))
    GRIFOLS USA, LLC
    Usage: HyperHEP B is indicated for post-exposure prophylaxis against hepatitis B virus in cases of acute exposure to HBsAg-positive blood, perinatal exposure in infants from HBsAg-positive mothers, sexual exposure to HBsAg-positive individuals, and household exposure to persons with acute HBV infection.

  • Sofosbuvir and velpatasvir (velpatasvir and sofosbuvir)

    (Velpatasvir and Sofosbuvir)
    Asegua Therapeutics LLC
    Usage: Sofosbuvir and velpatasvir is indicated for treating chronic hepatitis C virus (HCV) genotype 1-6 infection in adults and pediatric patients aged 3 years and older, including those without cirrhosis, with compensated cirrhosis, or with decompensated cirrhosis in combination with ribavirin.

  • Sovaldi access (sofosbuvir)

    (SOFOSBUVIR)
    Gilead Sciences Inc
    Usage: SOVALDI is indicated for treating chronic hepatitis C virus (HCV) in adults and pediatric patients aged 12 and older. It is used in combination with other antiviral agents for specific HCV genotypes, addressing those with or without cirrhosis.